Skip to main content
Clinical Trials/CTRI/2020/08/027146
CTRI/2020/08/027146
Recruiting
未知

A randomised controlled trial to study the early preterm delivery in pregnant women between supplemented with 200 mg/day and 1000 mg/day of DHA from second trimester. - DHA

Cloudnine Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Cloudnine Hospital
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Cloudnine Hospital

Eligibility Criteria

Inclusion Criteria

  • Pregnant females of 18\- 40 years of age
  • Gestational age 12\-20 weeks
  • \- Singleton pregnancy, irrespective of co morbidities
  • \- Dietary intake of DHA is \<200 mg/day
  • \- Available by telephone, to verify dietary compliance
  • \- South Asian population

Exclusion Criteria

  • \- Women with allergy to any component of DHA product (including algae), soybean oil or corn oil
  • \- Uterine anomalies
  • \- Women with fetal anomalies at 20 weeks or early, which may require termination of pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials